Los Angeles Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Pot Firm High On Nasdaq Bid

Medbox changes up its board and pot business as it looks to build buzz for a jump to Nasdaq.

By Marni Usheroff December 22, 2014 midnight   $$ Share

NantWorks Strikes Deal with Sorrento Therapeutics

NantWorks, billionaire Patrick Soon-Shiong’s Culver City holding company, has inked a deal with San Diego biopharmaceutical firm Sorrento Therapeutics Inc. to develop cancer and auto-immune disease treatments.

DCHS: Bucking Union, Members Support Sale to Prime

A growing number of union members at the six Daughters of Charity Health System hospitals in California have gone against their own union leadership and signed petitions in support of the sale of the hospitals to Prime Healthcare Services of Ontario, the hospital chain said.

Amgen Releases Results; FDA Approves XGEVA

Amgen Inc. has released detailed positive results from a study on cancer treatment Kyprolis, a key drug for the biopharmaceutical company that disappointed investors with earlier trial results.

NantHealth Unveils First Product of BlackBerry Collaboration

NantHealth, the health care technology division of billionaire Patrick Soon-Shiong’s Culver City holding company NantWorks, has revealed the first product of its collaboration with smartphone-maker BlackBerry: a secure clinical genome browser that gives doctors access to patients’ genetic data on the BlackBerry Passport smartphone.

Poll: Do you think vaping should be banned from public spaces?

Every week the Los Angeles Business Journal asks readers their views on a variety of business and economic issues. A running tally is available on the site and later will be published in the Commentary section of our print edition. Our latest poll is available on the bottom right column of our home page.

Montebello Man Sentenced to Three Years for Medicare Fraud

A physician’s assistant was sentenced Monday to three years in federal prison for defrauding Medicare out of millions of dollars by signing fraudulent prescriptions and other medical documents while working at two separate medical clinics in the Los Angeles area.

Amgen Halts Cancer Drug Trials After Deaths

Amgen Inc. announced on Monday it has ended two clinical studies on an experimental cancer drug after a preliminary review showed increased deaths among one group of patients.

Second Sight Soars in Market Debut

Shares of Second Sight Medical Products Inc. – the latest Alfred Mann company to go public – more than doubled Wednesday in its initial public offering.

CytRx Plunges: FDA Halts Trials After Patient Death

CytRx Corp. shares fell 9 percent Tuesday after the company announced the U.S. Food and Drug Administration had placed a hold on enrolling new patients in clinical trials of its experimental cancer drug following the death of a patient.

Second Sight Delays IPO

Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, delayed its planned $30 million IPO until Wednesday.

Second Sight's $30 Million IPO Set For Tuesday

Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, plans to launch a $30 million initial public offering on Tuesday.

MannKind Narrows Loss

MannKind Corp. posted narrow third-quarter losses on Monday as the company winds down its research operations and prepares to start selling its Afrezza brand inhalable insulin.

Two Indicted in Alleged L.A. Medicare Scheme

An owner of Los Angeles home health agency Fifth Avenue Home Health has been indicted for allegedly aiding in a $33 million scheme to defraud Medicare, the U.S. Justice Department announced Thursday.

Amgen Cuts Costs, Beats Estimates

Amgen posted third-quarter earnings Monday that beat Wall Street estimates, as the company reported strong drug sales and benefited from cost-cutting once restructuring costs were excluded.

Expanding USC Partners With Clinic Operator

USC’s medical system announced on Wednesday that it will partner with Surgical Care Affiliates Inc. to jointly manage surgery centers in the Los Angeles region, starting with one in Glendale.